OrthoPediatrics Is Maintained at Hold by Truist Securities
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Cuts Target Price to $28
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
A Quick Look at Today's Ratings for OrthoPediatrics(KIDS.US), With a Forecast Between $34 to $50
OrthoPediatrics Price Target Maintained With a $42.00/Share by Needham
OrthoPediatrics Analyst Ratings
Buy Rating Reaffirmed for OrthoPediatrics on Robust Growth Strategy and Strong Financials
BTIG Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $44
Piper Sandler Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Raises Target Price to $44
Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS)
Needham Reiterates Buy on OrthoPediatrics, Maintains $42 Price Target
OrthoPediatrics Analyst Ratings
OrthoPediatrics Analyst Ratings
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
OrthoPediatrics (KIDS) Gets a Hold From Truist Financial
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
OrthoPediatrics Outperforms With Strong Growth and Strategic Expansion: A Buy Rating Insight
OrthoPediatrics Analyst Ratings
No Data
No Data